TREATMENT OF HIGH-GRADE NON-HODGKINS-LYMPHOMAS WITH SHORT INTENSIVE CHEMOTHERAPY (MACOP-B)

被引：0

作者：

DELMER, A ^{[1
]}

BAUDUER, F ^{[1
]}

RUSKONEFOURMESTRAUX, A ^{[1
]}

AJCHENBAUMCYMBALISTA, F ^{[1
]}

DELMASMARSALET, B ^{[1
]}

RIO, B ^{[1
]}

MARIE, JP ^{[1
]}

ZITTOUN, R ^{[1
]}

机构：

[1] HOP HOTEL DIEU,SERV GASTROENTEROL,F-75181 PARIS 04,FRANCE

来源：

BULLETIN DU CANCER | 1993年 / 80卷 / 09期

关键词：

NON-HODGKINS LYMPHOMA; LARGE CELL; CHEMOTHERAPY; TOXICITY;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

We present our results of a MACOP-B regimen in a series of 46 patients with high-grade NHL. The complete remission rate was 74%for patients with advanced stage disease. The excellent tolerance allowed this regimen to be given on an outpatient basis in the majority of cases. The median follow-up for the living patients is 28 months. Although some patients received additional treatment that could influence the results, the predicted DFS (disease-free survival) at 45 months of 57% compares favorably with the best results published so far with more toxic regimens.

引用

页码：808 / 815

页数：8

共 50 条

[21] NUCLEOLAR ULTRASTRUCTURE IN LOW-GRADE AND HIGH-GRADE NON-HODGKINS-LYMPHOMAS
GOODLAD, JR
CROCKER, J
MACARTNEY, JC
JOURNAL OF PATHOLOGY, 1991, 163 (03): : 233 - 237
[22] TREATMENT OF AN AGGRESSIVE NON-HODGKINS-LYMPHOMA DURING PREGNANCY WITH MACOP-B CHEMOTHERAPY
NANTEL, S
PARBOOSINGH, J
POON, MC
MEDICAL AND PEDIATRIC ONCOLOGY, 1990, 18 (02): : 143 - 145
[23] INITIAL RISK ASSESSMENT AND TREATMENT STRATEGIES IN HIGH-GRADE MALIGNANT NON-HODGKINS-LYMPHOMAS
ENGELHARD, M
ONKOLOGIE, 1995, 18 (01): : 75 - 76
[24] PRELIMINARY-RESULTS OF THE MACOP-B REGIMEN IN PATIENTS WITH HIGH-GRADE MALIGNANT-LYMPHOMAS
OSTER, W
KRUGER, O
ZEILE, G
HERRMANN, F
MERTELSMANN, R
BLUT, 1986, 53 (03): : 224 - 225
[25] OPTIMIZATION OF RELATIVE DOSE-INTENSITY IN CHEMOTHERAPY OF ADULT HIGH-GRADE NON-HODGKINS-LYMPHOMAS
DUPRIEZ, B
PATHOLOGIE BIOLOGIE, 1994, 42 (01): : 120 - 121
[26] SEQUENTIAL VERSUS ALTERNATING CHEMOTHERAPY FOR HIGH-GRADE NON-HODGKINS-LYMPHOMAS - A RANDOMIZED MULTICENTER TRIAL
KOPPLER, H
PFLUGER, KH
ESCHENBACH, I
PFAB, R
BIRKMANN, J
ZELLER, W
STEINHAUER, EU
GROPP, C
OEHL, S
LOTZKE, E
KUHN, H
DRINGS, P
GOSSMANN, HH
LENNERT, K
STEIN, H
HAVEMANN, K
HEMATOLOGICAL ONCOLOGY, 1991, 9 (4-5) : 217 - 223
[27] G-CSF FOR TREATMENT INTENSIFICATION IN HIGH-GRADE MALIGNANT NON-HODGKINS-LYMPHOMAS
STEINKE, B
MANEGOLD, C
FREUND, M
REINOLD, HM
FISCHER, JT
ARNOLD, H
LENGFELDER, E
LUTZ, M
ZWINGERS, T
MUNZ, A
HECHT, T
ONKOLOGIE, 1992, 15 (01): : 46 - 50
[28] CHEMOTHERAPY WITH MACOP-B AND VACOP-B FOR INTERMEDIATE-GRADE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA - CLINICAL-RESULTS AND ANALYSIS OF PROGNOSTIC FACTORS
PICHERT, G
PETERS, J
STAHEL, RA
DOMMANN, C
JOSS, R
GEBBERS, JO
KRONER, T
SULSER, H
HONEGGER, HP
MAURER, R
PAMPALLONA, S
ANNALS OF ONCOLOGY, 1992, 3 (08) : 645 - 649
[29] TREATMENT INTENSIFICATION WITH R-METHUG-CSF IN HIGH-GRADE MALIGNANT NON-HODGKINS-LYMPHOMAS
STEINKE, B
MUNZ, A
MANEGOLD, C
FREUND, M
REINOLD, HM
FISCHER, JT
ARNOLD, H
LENGFELDER, E
LUTZ, M
HECHT, T
ZWINGERS, T
ONKOLOGIE, 1994, 17 (03): : 248 - 253
[30] STAGE-I HIGH-GRADE NON-HODGKINS-LYMPHOMAS - A RETROSPECTIVE ANALYSIS
GHERLINZONI, F
MAZZA, P
BOCCHIA, M
ZINZANI, PL
FIACCHINI, M
ZANCHINI, R
PILERI, S
TURA, S
HAEMATOLOGICA, 1991, 76 (01) : 38 - 42

← 1 2 3 4 5 →